Riskpilot← Back to searchSign inGet full accessEmbryo Aktiebolag
ABActiveOrg 5562252584Activities of holding companies · NACE 6421Est. 19830 employees
Revenue 2024
SEK 0
EBITDA margin
—
+6% vs 2023
Equity ratio
98.0%
Financial strength
Net profit 2024
SEK 0
0 employees
| Revenue | SEK 0 | — |
| EBITDA | SEK -78K | +6% |
| Net profit | SEK 0 | — |
| Total assets | SEK 52,7M | -9% |
| Equity | SEK 51,6M | -5% |
| Employees | 0 | — |
Legal name
Embryo Aktiebolag
Org number
5562252584
Legal form
Aktiebolag
NACE code
6421 · Activities of holding companies
Founded
11 februari 1983
Share capital
SEK 5 000 000 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas ensam av Willerman, Johan Anders
Company purpose
Bolaget skall bedriva konsultverksamhet i värdepappersförvaltning, äga och bedriva handel med fast egendom av alla slag, t ex värdepapper, ädelmetaller, ädelstenar, konst, antikviteter och möbler samt idka därmed förenlig verksamhet. Tillika äger bolaget rätt att för dotterbolag och närbesläktade företag samt tredje man ingå borgensåtagande, så och till dessa lämna lån, dock ej innefattande sådan verksamhet, som avses i lagen om bankrörelse eller lagen om kreditrörelse.
Address
Phone
+4619278200
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −73 | −27 | −94 | −83 | −78 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | −73 | −27 | −94 | −83 | −78 |
| Net financials | — | — | — | — | — |
| Profit before tax | −73 | −27 | −94 | 0 | 0 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | −73 | −27 | −94 | 0 | 0 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 68 806 | 66 286 | 57 738 | 57 704 | 52 704 |
| Equity | 65 268 | 62 741 | 56 647 | 54 147 | 51 647 |
| Long-term debt | 1 038 | 1 038 | 1 038 | 1 038 | 1 038 |
| Short-term debt | 2 500 | 2 508 | 54 | 2 520 | 20 |
| Total debt | 3 538 | 3 546 | 1 092 | 3 558 | 1 058 |
EBITDA margin
-7800000.0%
This company
15.8%
Market median
-49367189% vs market
20202024
Equity ratio
98.0%
This company
38.2%
Market median
+157% vs market
20202024
Return on equity
0.0%
This company
18.4%
Market median
-100% vs market
20202024
Net profit margin
0.0%
This company
8.1%
Market median
-100% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
0.02×
This company
0.62×
Market median
+97% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
HO Audit | Audit | 2022 |
JA Chief Executive Officer | Chief Executive Officer | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Chairman | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Embryo Aktiebolag 
W-Invest Fastigheter AktiebolagBoard members of Embryo Aktiebolag also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Hans Oskar Olsson | Audit | 0 companies |
| Johan Anders Willerman | Chief Executive Officer | 0 companies |
| Per Roland Andersson | Chairman | 0 companies |
| Kurt Anders Carlsson | Board of Directors | 0 companies |